HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Primum non nocere: do we harm stage I testicular cancer patients less by applying adjuvant chemotherapy than by failing to present this option?

AuthorsJ Oldenburg, M Cullen, T Tandstad
JournalAnnals of oncology : official journal of the European Society for Medical Oncology (Ann Oncol) Vol. 26 Issue 2 Pg. 255-6 (Feb 2015) ISSN: 1569-8041 [Electronic] England
PMID25395282 (Publication Type: Editorial)
Chemical References
  • Bleomycin
  • Etoposide
  • Cisplatin
Topics
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Bleomycin (therapeutic use)
  • Chemotherapy, Adjuvant (methods)
  • Cisplatin (therapeutic use)
  • Etoposide (therapeutic use)
  • Humans
  • Male
  • Neoplasms, Germ Cell and Embryonal (drug therapy)
  • Risk Assessment
  • Testicular Neoplasms (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: